Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: In vivo and in vitro

Pancreas

Volumn 26, Issue 3, 2003, Pages 292-299

  Kim, Myung Jun ^a   Ryu, Gyeong Ryul ^a   Chung, Ji Sung ^a   Sim, Sang Soo ^b   Min, Do Sik ^a   Rhie, Duck Joo ^a   Yoon, Shin Hee ^a   Hahn, Sang June ^a   Kim, Myung Suk ^a   Jo, Yang Hyeok ^a  

^a The Catholic University of Korea   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Epicatechin; Insulin; Islets; Nitrite; Streptozotocin

Indexed keywords

EPICATECHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; RISK BENEFIT ANALYSIS; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CATECHIN; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN; MALE; NITRITES; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 12244297093     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200304000-00014     Document Type: Article

References (46)

1. Nattrass M. Etiology of diabetes mellitus. In: Nattrass M, ed. Malin's clinical diabetes. 2nd ed. London: Chapman & Hall Medical, 1996:1-21.
2. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970;22:485-518.
3. Coleman DL. Diabetes mellitus in rodents. In: Andrews EJ, Ward BC, Altman NH, eds. Spontaneous animal models of human disease. New York: Academic Press, 1979:126-31.
4. Weiss RB. Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep 1982;66:427-38.
5. Iritani N, Sugimoto T, Fukuda H, et al. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 1997;127:1077-83.
6. Lavigne C, Marette A, Jacques H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 2000;278:E491-500.
7. Yang CS. Tea and health. Nutrition 1999;15:946-9.
8. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704.
9. Dashwood RH, Xu M, Hernaez JF, et al. Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc Soc Exp Biol Med 1999;220:239-43.
10. Haqqi TM, Anthony DD, Gupta S, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 1999;96:4524-9.
11. Chakravarthy BK, Gupta S, Gambhir SS, et al. Pancreatic beta-cell regeneration in rats by (-)-epicatechin. Lancet 1981;2:759-60.
12. Chakravarthy BK, Gupta S, Gode KD. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci 1982;31:2693-7.
13. Bone AJ, Hii CST, Brown D, et al. Assessment of the antidiabetic activity of epicatechin in streptozotocin diabetic and spontaneously diabetic BB/E rats. Biosci Rep 1985;5:215-21.
14. Hii CST, Howell SL. Effects of epicatechin on rat islets of Langerhans. Diabetes 1984;33:291-6.
15. 2+ handling in rat islets of Langerhans. J Endocrinol 1985;107:1-8.
16. Ahmad F, Khalid P, Khan MM, et al. Insulin like activity in (-) epicatechin. Acta Diabetol Lat 1989;26:291-300.
17. Takabayashi F, Harada N, Hara Y. The effects of green tea catechins (Polyphenon) on DL-ethionine-induced acute pancreatitis. Pancreas 1995;11:127-31.
18. Takabayashi F, Harada N. Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats. Pancreas 1997; 14:276-9.
19. Sheehan EW, Stiff DD, Duah F, et al. The lack of effectiveness of (-)-epicatechin against alloxan-induced diabetes in Wistar rats. Life Sci 1983;33:593-7.
20. Eizirik DL, Sandler S, Welsh N, et al. Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 1988;122:1242-9.
21. Corbett JA, Lancaster JR Jr, Sweetland MA, et al. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1β-induced inhibition of insulin secretion. J Biol Chem 1991;266:21351-4.
22. Corbett JA, Wang JL, Sweetland MA, et al. Interleukin-1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. J Clin Invest 1992;90:2384-91.
23. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 1992;41:897-903.
24. National Institutes of Health. Guide for the care and use of laboratory animals. NIH publication no. 80-23. Bethesda, MD: National Institutes of Health, 1996.
25. Kim M-J, Lee Y-S, Lee K-H, et al. Site-specific localization of protein kinase C isoforms in rat pancreas. Pancreatology 2001;1:36-42.
26. Bolkent S, Yilmazer S, Ozturk M. Combined non-radioactive detection of peptide hormones and their mRNAs in stomach somatostatin cells. Regul Pept 1995;59: 17-21.
27. Kim M-J, Lee K-H, Min DS, et al. Distributional patterns of phospholipase C isozymes in rat pancreas. Pancreas 2001;22:47-52.
28. Park C, Kim J-R, Shim J-K, et al. Inhibitory effects of streptozotocin, tumor necrosis factor-α, and interleukin-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch Biochem Biophys 1999; 362:217-24.
29. Vinik A, Rafaeloff R, Pittenger G, et al. Induction of pancreatic islet neogenesis. Horm Metab Res 1997;29:278-93.
30. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298:249-58.
31. Marletta MA, Yoon PS, Iyengar R, et al. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988;27:8706-11.
32. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rey 1991;43:109-42.
33. Henquin J-C. Cell biology of insulin secretion. In: Kahn CR, Weir G, eds. Joslin's diabetes mellitus. 13th ed. Philadelphia: Williams & Wilkins, 1994:56-80.
34. Valsa AK, Sudheesh S, Vijayalakshmi NR. Effect of catechin on carbohydrate metabolism. Indian J Biochem Biophys. 1997;34:406-8.
35. Tijburg LB, Mattern T, Folts JD, et al. Tea flavonoids and cardiovascular disease. Crit Rev Food Sci 1997;37:771-85.
36. Katiyar SK, Agarwal R, Mukhtar H. Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment. Carcinogenesis 1993;14:2641-3.
37. Katiyar SK, Agarwal R, Zaim MT, et al. Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 1993;14:849-55.
38. Yang CS, Chen L, Lee M-J, et al. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998;7:351-4.
39. Zhu M, Chen Y, Li RC. Pharmacokinetics and system linearity of tea catechins in rat. Xenobiotica 2001;31:51-60.
40. Chakrawarthy BK, Gupta S, Gambhir SS, et al. Pancreatic B cell regeneration - a novel antidiabetic mechanism of Pterocarpus marsupium Roxb. Ind J Pharmacol 1980;12:t23-7.
41. Strandell E, Eizirik DL, Korsgren O, et al. Functional characteristics of cultured mouse pancreatic islets following exposure to different streptozotocin concentrations. Mol Cell Endocrinol 1988;59:83-91.
42. Kullin M, Li Z, Hansen JB, et al. KATP channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes 2000;49:1131-6.
43. Turk J, Corbett JA, Ramanadham S, et al. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun 1993;197:1458-64.
44. Spinas GA. The dual role of nitric oxide in islet β-cells. News Physiol Sci 1999;14:49-54.
45. Takamura T, Kato I, Kimura N, et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic β-cells develop insulin-dependent diabetes without insulitis. J Biol Chem 1998;273:2493-6.
46. Chan MM-Y, Fong D, Ho C-T, et al. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 1997;54:1281-6.